Navigation Links
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Date:7/23/2014

rating with ArmaGen and leveraging our ability to successfully develop medicines to treat this rare, life-threatening disease."

Shire researched, developed and commercialized the first treatment approved for Hunter syndrome. This agreement with ArmaGen expands Shire's commitment to finding treatments for Hunter syndrome, which also includes SHP-609, Shire's product currently being investigated to treat the CNS manifestations associated with Hunter syndrome.

James Callaway, Ph.D., Chief Executive Officer of ArmaGen said, "Shire is the ideal partner for AGT-182, based on the company's international reach and expertise in serving patients with Hunter syndrome. We look forward to beginning the Phase I/II clinical trial of AGT-182 in collaboration with Shire and leveraging their expertise with these patients."  

About AGT-182

AGT-182, which has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is designed to take advantage of the body's natural system for transporting products across the blood brain barrier (BBB) by using the same receptor that delivers insulin to the brain. AGT-182 is engineered by the fusion of the replacement IDS enzyme to an antibody that binds to a receptor on the BBB. The IDS enzyme is designed to cross the BBB attached to that antibody.

About Hunter syndrome (MPS II)

Hunter syndrome or Mucopolysaccharidosis II (MPS II) is a rare, life-threatening genetic disorder that results from the absence or insufficient levels of the lysosomal enzyme iduronate-2-sulfatase. Without this enzyme, cellular waste products called mucopolysaccharides, also known as glycosaminoglycans or GAGs accumulate in tissues and organs, which then begin to malfunction. Possible signs and symptoms include large head, enlarged abdomen, frequent ear infections, difficulty breathing, joint stiffness, and short stature. It is estim
'/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
6. Shire Changes its NASDAQ Ticker Symbol to SHPG
7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
9. Shire Reaches Agreement in Principle With U.S. Government
10. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
11. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... Ottawa, ON (PRWEB) , ... June 26, 2015 ... ... kits and end-to-end services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) ... innovative microbiome research, as part of its Gut Microbiome Grant Program. The company ...
(Date:6/25/2015)... , June 25, 2015 Last June, a dedicated ... track the virus using large-scale genome sequencing. Their research, which ... 18 in the journal Cell (Park 2015) ... mutated over seven months of the recent Ebola outbreak. ... working draft, data, workflows, and full edit history of the ...
(Date:6/25/2015)... (PRWEB) , ... June 25, 2015 , ... ... of keynotes speakers for its 2015 National Patient and Family Conference, Providing and ... in Chicago at the Renaissance Chicago O’Hare Suites Hotel, July 24-25, 2015. , ...
(Date:6/25/2015)... 25, 2015  The Galien Awards Committee announced today ... and Medical Genetics at the University of Washington and ... Award at the ninth annual Prix Galien ... The Pro Bono Humanum Award recognizes ground-breaking efforts ... woman recipient of the award.   The Galien ...
Breaking Biology Technology:DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3Open Science Takes Major Leap Forward 2Nationally Recognized Brain Tumor Experts to Speak at American Brain Tumor Association Patient and Family Conference 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 3
... students Steven T. Evans, Tobias Voitl, Gabriel R. Rodriguez-Rivera, ... MADISON - Carbon monoxide, or CO, has long been ... fuel cells. But now, chemical and biological engineers at ... barrier - they also have discovered a method to ...
... have mercy, otherwise, our produce will not be discovered and ... day. The festivities are full steam ahead, the skateboarding mathematicians ... sticks while sipping champagne, and they are now calculating the ... ,Looking from a wider angle, it seems that the big ...
... Thursday with Capital Data, Inc. , an ... services, according to TeraMEDICA's executive vice president, Paul ... bundle TeraMEDICA's TI2m archive solution into its own ... that includes Wisconsin, Minnesota, North Dakota, South Dakota, ...
Cached Biology Technology:UW engineers clear bottleneck in hydrogen production 2Lord of the Engines 2Lord of the Engines 3TeraMEDICA and Capital Data enter into diagnostic imaging agreement 2
(Date:6/26/2015)... -- ATL Technology, LLC, a top provider of electromechanical contract ... solutions, headquartered in Springville, Utah , has ... corporation with locations in Santa Clara, ... ). This acquisition will incorporate MedConx,s manufacturing ... Technology,s existing facility in Costa Rica , ...
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
(Date:6/24/2015)... JOSE, Calif. , June 24, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... sensor to provide secure authentication for its latest ... recently reached more than 200 million shipments of ... with Sharp reinforces Synaptics, strength, scalability and leadership ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... exposed to low doses of atrazine, a widely used herbicide, ... through puberty later than non-exposed animals. The research adds to ... used to control weeds and grasses in crops such as ... to be relatively persistent in the environment, potentially finding their ...
... current issue of Deutsches rzteblatt International (Dtsch ... pharmacologist, and coauthors present the PRISCUS List: a list ... effects when given to elderly patients. The authors ... Germany in the setting of a joint project entitled ...
... Chinese on EurekAlert! Chinese . ... Medicine, Hershey, Pennsylvania have discovered that the Opioid Growth ... important system with potent antitumor properties, has controlled entry ... passage of OGF-OGFr is critical to cell proliferation and ...
Cached Biology News:Atrazine causes prostate inflammation in male rats and delays puberty 2Regulation of cell proliferation is dependent on nucleocytoplasmic trafficking 2Regulation of cell proliferation is dependent on nucleocytoplasmic trafficking 3
...
AgarPlaque Plus Agarose 50 grams...
DL-Dithiothreitol (Clelands Reagent) ,PROTEASE FREE!! ,Molecular Biology Grade ,PRODUCT MUST SHIP NEXT DAY DURING HOT SUMMER MONTHS. ,C 4 H 10 O 2 S 2 ,Molecular Weight: 154.25 ,CAS RN: [27565-...
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells...
Biology Products: